ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

GRTX Company Profile and Key Details

NASDAQ : GRTX

Galera Therapeutics, Inc.

$0.03

-0.0005-1.51%

At Close 4:00 PM

69.07

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

GRTX Stock Price Chart

Stock Price Today

Galera Therapeutics, Inc. (GRTX) stock surged +1.54%, trading at $0.03 on NASDAQ, up from the previous close of $0.03. The stock opened at $0.03, fluctuating between $0.03 and $0.03 in the recent session.

Stock Snapshot

0.0325

Prev. Close

0.03

Open

2.49M

Market Cap

75.46M

Number of Shares

0.0325

Day Low

0.033

Day High

-0.11

P/E Ratio

42.14%

Free Float in %

-0.29

EPS (TTM)

-2.41

Book Value

-0.83

Cash Flow per Share

1.33K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 28, 2025	0.03	0.03	0.03	0.03	1.33K
Mar 27, 2025	0.03	0.03	0.03	0.03	46.45K
Mar 26, 2025	0.03	0.04	0.03	0.03	74.6K
Mar 25, 2025	0.03	0.03	0.03	0.03	11.36K
Mar 24, 2025	0.03	0.03	0.03	0.03	1.13K
Mar 21, 2025	0.03	0.04	0.03	0.03	336.8K
Mar 20, 2025	0.03	0.03	0.03	0.03	3.15K
Mar 19, 2025	0.04	0.04	0.03	0.04	3.6K
Mar 17, 2025	0.04	0.04	0.04	0.04	3.7K
Mar 14, 2025	0.03	0.04	0.03	0.03	56.1K
Mar 13, 2025	0.04	0.04	0.04	0.04	1.72K
Mar 12, 2025	0.04	0.04	0.04	0.04	63.51K
Mar 11, 2025	0.04	0.04	0.04	0.04	5.3K
Mar 10, 2025	0.04	0.04	0.04	0.04	140.43K
Mar 07, 2025	0.04	0.04	0.04	0.04	10.75K
Mar 06, 2025	0.04	0.04	0.04	0.04	13.8K
Mar 05, 2025	0.04	0.04	0.04	0.04	10K
Mar 04, 2025	0.04	0.04	0.04	0.04	2.8K
Mar 03, 2025	0.04	0.04	0.04	0.04	205.5K
Feb 28, 2025	0.04	0.04	0.04	0.04	23.5K

Contact Details

Malvern, PA 19355

United States

Website: https://www.galeratx.comContact: 610 725 1500

About Company

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Frequently Asked Questions

What is the current Galera Therapeutics, Inc. (GRTX) stock price?

Galera Therapeutics, Inc. (NASDAQ: GRTX) stock price is $0.03 in the last trading session. During the trading session, GRTX stock reached the peak price of $0.03 while $0.03 was the lowest point it dropped to. The percentage change in GRTX stock occurred in the recent session was 1.54% while the dollar amount for the price change in GRTX stock was $0.00.

GRTX's industry and sector of operation?

The NASDAQ listed GRTX is part of Biotechnology industry that operates in the broader Healthcare sector. Galera Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GRTX?

Dr. J. Mel Sorensen M.D.
Chief Executive Officer, Pres & Director
Mr. Christopher Degnan
Chief Financial Officer
Mr. Mark J. Bachleda M.B.A., Pharm.D.
Chief Commercial Officer
Dr. Robert A. Beardsley M.B.A., Ph.D.
Co-Founder & Chief Operating Officer
Dr. Dennis P. Riley Ph.D.
Chief Scientific Officer, Emeritus
Ms. Jennifer Evans Stacey Esq.
Chief Legal & Compliance Officer and Sec.
Ms. Andie Collier
Chief Regulatory & Quality Officer
Ms. Judy Schnyder
Senior Vice President of Clinical Operations & Data Management
Dr. Eugene P. Kennedy F.A.C.S., FACS, M.D.
Chief Medical Officer
Dr. Jon T. Holmlund M.D.
Executive Officer

How GRTX did perform over past 52-week?

GRTX's closing price is 54.76% higher than its 52-week low of $0.02 where as its distance from 52-week high of $0.24 is -86.4%.

How many employees does GRTX have?

Number of GRTX employees currently stands at 7.

Link for GRTX official website?

Official Website of GRTX is: https://www.galeratx.com

How do I contact GRTX?

GRTX could be contacted at phone 610 725 1500 and can also be accessed through its website. GRTX operates from 2 West Liberty Boulevard, Malvern, PA 19355, United States.

How many shares of GRTX are traded daily?

GRTX stock volume for the day was 1.33K shares. The average number of GRTX shares traded daily for last 3 months was 127.41K.

What is the market cap of GRTX currently?

The market value of GRTX currently stands at $2.49M with its latest stock price at $0.03 and 75.46M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	7
Beta	2.06
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology